Latest Breaking News On - B cell activating factor - Page 1 : comparemela.com

Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce

Raises Concerns Surrounding Lucien Selce s Self-Serving Proposals and Lack of Credibility Glass Lewis Recommends that Aurinia Shareholders Vote FOR the Re-Election to the Board of Directors of All.

United statesDouglas miehmLucien selceEd arceMaury raycroftAdvisory serviceAurinia pharmaceuticalsExchange commission electronic document gatheringAurinia pharmaceuticals incFellow shareholdersB cell activating factorProliferation inducing ligandNew directorsDeep industryLeadership experienceLeading independent proxy advisory

Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce

Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaNew yorkAndrea christopherLucien selceMaury raycroftBarbara shecterGabriel friedmanJustin trudeauJoe oconnorHoward levittDouglas miehmGwyn morganEd arceExchange commission electronic document gatheringPostmedia network inc

Vera Therapeutics Presents 72-week eGFR Stabilization and

Vera Therapeutics Presents 72-week eGFR Stabilization and
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Joyce allaireMari purpuraRichard lafayetteMarshall fordyceVera therapeutics incDivision of nephrologyCongress paper selection committeeUniversity of aachenEuropean renal association congressExchange commissionResults are consistent withPaper selectionFree communicationOpen label extensionIga nephropathyPersistent proteinuria

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress

Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Joyce allaireMarshall fordyceRichard lafayetteMari purpuraCongress paper selection committeeGlobenewswire incDivision of nephrologyUniversity of aachenExchange commissionEuropean renal association congressStanford glomerular disease centerStanford university medical centerVera therapeutics incRenal association congressResults are consistent withPaper selection

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Robertm brennerJoyce allaireMari purpuraMarshall fordyceWilliamd turnerAmplyx pharmaceuticals incPfizer incEuropean renal association congressExchange commissionVera therapeutics incRecent business highlightsChief medical officerChief developmentQuarter ended marchB cell activating factorInducing ligand